Search:

Results 1 to 10 of 38 |

How medicines are born : the imperfect science of drugs / by Vozza, Lisa,author.(CARDINAL)894505; D'Incalci, Maurizio,author.(CARDINAL)893893; Gescher, Andreas,translator.(CARDINAL)894506;
Includes bibliographical references and index.To cure, heal or repair -- Hunting for drugs -- Laboratory studies -- First time in humans -- Only probabilities, never certainties -- Approval or rejection -- Vigilance, revisions, new indications -- Predicting the drugs of the future -- Not every pill is a proper drug -- If you want to know more -- Myths to be dispelled -- Did you know that
Subjects: Drug development.; Drugs; Drug development; Pharmaceutical technology.; Medication.;
Available copies: 1 / Total copies: 1
unAPI

Ten drugs : how plants, powders, and pills have shaped the history of medicine / by Hager, Thomas,author.(CARDINAL)755353;
"Beginning with opium, the "joy plant," which has been used for 10,000 years, Hager tells a captivating story of medicine. His subjects include the largely forgotten female pioneer who introduced smallpox inoculation to Britain, the infamous knockout drops, the first antibiotic, which saved countless lives, the first antipsychotic, which helped empty public mental hospitals, Viagra, statins, and the new frontier of monoclonal antibodies. This is a deep, wide-ranging, and wildly entertaining book."--Page [2] of cover.Includes bibliographical references (pages 277-285) and index.
Subjects: Pharmacology; Drugs; Medicine; Pharmaceutical technology; Medication.;
Available copies: 2 / Total copies: 3
unAPI

Anacondas [videorecording] : the hunt for the blood orchid / by Byrd, Eugene,1975-; Little, Dwight H.; Marsden, Matthew,1972-; Messner, Johnny,1970-; Richardson-whitfield, Salli,1967-; Strickland, KaDee,1977-; Tyson-Chew, Nerida.; Windon, Stephen F.,1959-; Columbia TriStar Home Entertainment (Firm)(CARDINAL)332237;
Director of photography, Stephen F. Windon ; editors, Marcus D'Arcy, Mark Warmer ; music, Nerida Tyson-Chew ; costume designer, Terry Ryan ; production designer, Bryce Perrin.Johnny Messner, KaDee Strickland, Matthew Marsden, Eugene Byrd, Salli Richardson-Whitfield, Nicholas Gonzalez, Karl Yune, Denis Arndt, Morris Chestnut.The blood orchid is a rare flower that holds the secret to eternal life and a fortune to the pharmaceutical company that finds it. Led by a two-fisted soldier of fortune, a scientific expedition is sent deep into the jungles of Borneo to locate and bring back samples of the legendary plant. Battling their way upriver, the explorers brave poisonous insects, ferocious crocodiles and savage headhunters, unaware that they are being stalked by an even greater danger: a nest of giant anacondas, who'll stop at nothing to protect their breeding groud, the blood orchid's home.MPAA rating: PG-13; for action violence, scary images and some language.DVD, region 1, full screen (1.33:1) and widescreen presentations; Dolby Digital.
Subjects: Fiction films.; Horror fiction.; Thrillers (Fiction); Anaconda; Feature films.; Films for the hearing impaired; Orchids; Pharmaceutical technology; Scientific expeditions;
Available copies: 8 / Total copies: 14
unAPI

Internet tools of the profession : a guide for special librarians / by Tillman, Hope N.(CARDINAL)207417;
Includes bibliographical references and index.Searching on the Internet. -- SLA discussion groups and other Internet resources. -- Business and finance. -- Chemistry. -- Education. -- Food, agriculture and nutrition. -- Information technology, networking section. -- Nuclear science. -- Pharmaceutical. -- Internet subject sampler: divisions and caucuses.Provides a select list with full dwscriptin of Internet-accessible resources indentified as valuable by participating divisions, cauceses, or other SLA units. Identifies the value added provided by the resources, or in other words to describe how these tools, sites, and resources made a difference to unit members.
Subjects: Directories.; Databases.; Computer network resources.; Internet addresses; Humanities;
Available copies: 1 / Total copies: 1
On-line resources: Suggest title for digitization;
unAPI

3D printing and medicine / by Blohm, Craig E.,1948-author.(CARDINAL)663489;
Grade 9 to 12.Includes bibliographical references and index.The evolution of 3D printing -- Replacing organs -- Creating new body parts -- Printing pharmaceuticals -- 3D printing in surgery and research.3D printing is revolutionizing health care. 3D printers are now used to make low-cost prostheses, replace diseased organs, produce new pharmaceuticals, and create models to guide surgeons through difficult operations. This cutting-edge technology has the potential to make health care more affordable, more personalized, and more available to people around the world.
Subjects: Young adult literature.; Young adult literature.; Medical technology.; Three-dimensional printing.;
Available copies: 2 / Total copies: 4
unAPI

Commission on the Federal Drug Approval Process : final report / by United States.Commission on the Federal Drug Approval Process.(CARDINAL)281518; United States.Congress.House.Committee on Science and Technology.Subcommittee on Investigations and Oversight.(CARDINAL)281266; United States.Congress.House.Committee on Science and Technology.Subcommittee on Natural Resources, Agriculture Research, and Environment.(CARDINAL)281265;
Includes bibliographical references.
Subjects: United States. Food and Drug Administration.; Drug approval; Drugs; Pharmaceutical policy;
Available copies: 1 / Total copies: 1
On-line resources: Suggest title for digitization;
unAPI

Resumes that knock 'em dead / by Yate, Martin John.(CARDINAL)184035;
Includes bibliographical references (pages 285-290) and index.
Subjects: Résumés (Employment);
Available copies: 3 / Total copies: 5
unAPI

Why moats matter : the Morningstar approach to stock investing / by Brilliant, Heather.(CARDINAL)406834; Collins, Elizabeth,1979-(CARDINAL)407468; Morningstar, Inc.(CARDINAL)767909;
"Economic moats, referring to the advantages a company has over its competitors, are competitive structures that help great companies continue to be great investments. Stock in a company with a wide economic moat is usually a much safer investment. This book will: Introduce Morningstar's approach to investing Establish the difference between business quality and undervalued stocks Explain economic moat and its network effect, cost benefits, and efficient scales Discuss industry standards for determining moats Help determine what moat means for stock returns and their impact on stock valuation "--Machine generated contents note: ch. 1 Guiding Principles of Morningstar's Equity Research -- Question 1: How Can We Identify Which Businesses Are Great? -- Question 2: When Is the Best Time to Invest in Great Businesses? -- ch. 2 What Makes a Moat? -- Moat Sources -- Notes -- ch. 3 Why Moat Trends Matter -- Contributed by Stephen Ellis, a member of Morningstar's Economic Moat Committee and head of Financial Services equity research at Morningstar -- Moat Trends and Fundamental Performance -- Five Key Considerations for Moat Trends -- Intangibles -- Cost Advantage -- Switching Costs -- Network Effect -- Efficient Scale -- Best Practices for Moat Trend Analysis -- ch. 4 How Stewardship Affects Economic Moats -- Contributed by Todd Wenning, who oversees Morningstar's equity stewardship methodology -- Meet Our Stewardship Methodology -- Drilling Down -- ch. 5 Applying Moats to Dividend Investing.Contents note continued: Contributed by Josh Peters, director of equity-income strategy for Morningstar and editor of the Morningstar® DividendlnvestorSM newsletter -- Why Dividends Matter -- Which Dividends? -- ch. 6 The Importance of Valuation -- Contributed by Joel Bloomer, Matt Coffina, and Gareth James, members of Morningstar's Moat Committee and contributors to Morningstar's valuation methodology -- Valuation Concepts -- Cost of Capital and Returns on Capital -- Morningstar's Valuation Approach -- Example: Calculating ROIC -- Forecasting Future Free Cash Flows -- The Morningstar Rating[™] for Stocks -- Fair Value Uncertainty and Cost of Equity -- Notes -- ch. 7 Do Moat Ratings Predict Stock Returns? -- Contributed by Warren Miller, head of quantitative research at Morningstar -- ch. 8 Putting Moat and Valuation to Work: Portfolio Strategies -- Wide Moat Focus Index -- The Tortoise and Hare Portfolios -- ch. 9 Basic Materials -- Commodity Manufacturers.Contents note continued: Commodity Processors -- Metals and Mining -- ch. 10 Consumer -- Beverages -- Consumer Products -- Tobacco -- Restaurants -- Retail Defensive -- Specialty Retail -- Lodging -- Notes -- ch. 11 Energy -- Oil and Gas Drilling -- Oil and Gas Exploration and Production -- Oil and Gas Midstream -- Refining -- Oil and Gas Integrateds -- Engineering Services -- ch. 12 Financial Services -- Banks -- Capital Markets -- Credit Services -- Financial Exchanges -- Insurance -- ch. 13 Healthcare -- Pharmaceuticals -- Biotechnology -- Medical Devices -- Medical Instruments and Supplies -- Diagnostics and Research -- ch. 14 Industrials -- Railroads -- Airport Operators -- Aerospace and Defense -- Trucking and Marine Shipping -- Waste Management -- Heavy Equipment -- Diversified Industrials -- ch. 15 Technology -- Consumer Technology -- Enterprise Hardware Systems -- IT Services -- Semiconductors -- Software -- Telecom Services -- ch. 16 Utilities.Contents note continued: Regulated and Diversified Utilities -- Independent Power Producers.
Subjects: Stocks.; Investment analysis.;
Available copies: 1 / Total copies: 1
unAPI

Fit to compete : why honest conversations about your company's capabilities are the key to a winning strategy / by Beer, Michael,author.(CARDINAL)842100;
Introduction: Why your strategy needs an honest conversation -- Part I. The power of honest conversations: How to lead an honest conversation -- Why honest conversations are transformative -- Part II. How and why honest conversations work: Fit to compete: becoming a corporate Olympian -- Fit to perform: overcoming the 'silent killers' -- "Fit to trust: overcoming hierarchy -- "Fit to adapt: the missing strategic learning and governance process -- Part III. What if honest conversations were the norm?: Corporate stewardship demands honest conversations -- Honest conversations demand courage."In thirty years of working in corporations, Michael Beer has witnessed how organizational silence has derailed many a strategic objective. When lower-level employees in the organization can't speak truth to power, senior leaders don't hear what they need to hear about their firm's fitness to compete. Employees lose trust in higher-ups and become more resistant to change. In Fit to Compete, Beer presents an antidote to silence--an innovative and highly effective process for holding honest conversations with everyone in your organization. Used by over 150 organizations across the globe, the Strategic Fitness Process has helped leaders in industries as diverse as medical technology, restaurant chains, and pharmaceuticals hear the raw and necessary truth about the sources of misalignment between their strategies and their organizations. In addition to a step-by-step guide, Beer offers detailed and illustrative case studies of companies that have used the Strategic Fitness Process to great effect. He also shows how to apply the process more broadly, to a variety of strategic challenges and at multiple levels throughout the organization"--
Subjects: Communication in management.; Honesty.; Organizational behavior.; Organizational effectiveness.; Trust.;
Available copies: 1 / Total copies: 1
unAPI

Four good reasons : a Kenna Devlin mystery / by Francis, Kate;
Private Investigator Kenna Devlin, still recovering from injuries sustained in her last case, agrees to track down the guy who "ghosted" her friend. He was a security guard at a pharmaceutical company, and he vanished without a trace. She quickly realizes he isn't the first person at Cantaldi Pharmaceuticals to die, nor will he be the last. When her lover, FBI Agent Paul Smith, disappears while investigating a cold case at the same company, she frantically digs into her own family history to figure out the connection. What she learns challenges everything she thought she knew about her life. Soon she has a bigger problem - keeping herself alive long enough to stop the killings. Past and present collide as Kenna and Paul struggle to stop those who would sell dangerous medical technology to the highest bidder.
Subjects: Detective and mystery fiction.; Cold cases; Murder;
© 2022., [Kate Francis],
Available copies: 1 / Total copies: 1
unAPI

Results 1 to 10 of 38 |